Profusa (PFSA) Non-Current Deferred Tax Liability (2022 - 2023)
Profusa posted quarterly Non-Current Deferred Tax Liability of $13661.0 for Q4 2023, down 63.02% year-on-year from $36940.0 in Q4 2022, and down 98.92% on a QoQ basis from $1.3 million in Q3 2023.
Profusa (PFSA) has 2 years of Non-Current Deferred Tax Liability data on file, last reported at $13661.0 in Q4 2023.
- For the quarter ending Q4 2023, Non-Current Deferred Tax Liability fell 63.02% year-over-year to $13661.0; the trailing twelve-month figure through Dec 2023 stood at $13661.0 (down 63.02% YoY), and the FY2023 full-year result was $13661.0, down 63.02% from the prior year.
- Non-Current Deferred Tax Liability for Q4 2023 stood at $13661.0, down from $1.3 million in the prior quarter.
- Across five years, Non-Current Deferred Tax Liability topped out at $1.3 million in Q3 2023 and bottomed at $13661.0 in Q4 2023.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Profusa | 574,294.01 | 574,294.01 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | 13,661.00 |
| Dec 31, 2023 | 13,661.00 |
| Sep 30, 2023 | 1.27 Mn |
| Sep 30, 2023 | 1.27 Mn |
| Jun 30, 2023 | 735,048.00 |
| Jun 30, 2023 | 735,048.00 |
| Dec 31, 2022 | 36,940.00 |
| Dec 31, 2022 | 36,940.00 |